Additionally, the antitumor drug gemcitabine was demonstrated to induce urokinase-type plasminogen activator (uPA)-mediated invasion, spheroid formation, and resistance to apoptosis in CSC-like cells from pancreatic carcinoma [25]. This evidence concerns the gene PLAU and exocrine pancreatic carcinoma.